Antibody avidity
Use of Immunoglobulin G Antibody Avidity for Differentiation of Primary Human Herpesvirus 6 and 7 Infections
5
Anti-Leishmania infantum IgG Antibody Avidity in Visceral Leishmaniasis
6
Antibody Avidity in Humoral Immune Responses in Bangladeshi Children and Adults following Administration of an Oral Killed Cholera Vaccine
8
Human Immunodeficiency Virus Antibody Avidity Testing to identify recent infection among the newly diagnosed HIV-1 infected individuals and the effect of Antiretroviral Therapy on the Avidity Antibodies: A Pilot study
118
Viral Persistence Induces Antibody Inflation without Altering Antibody Avidity
10
Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection
6
Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein denaturing agent is employed
5
TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen
11
Concentration and High Avidity of Pneumococcal Antibodies Persist at Least 4 Years after Immunization with Pneumococcal Conjugate Vaccine in Infancy
7
Changes in Avidity and Level of Immunoglobulin G Antibodies to Mycobacterium tuberculosis in Sera of Patients Undergoing Treatment for Pulmonary Tuberculosis
8
Isolation and characterization of a mutant liver aldolase in adult hereditary fructose intolerance Identification of the enzyme variant by radioassay in tissue biopsy specimens
14
Avidity of the Immunoglobulin G Response to a Neisseria meningitidis Group C Polysaccharide Conjugate Vaccine as Measured by Inhibition and Chaotropic Enzyme-Linked Immunosorbent Assays
7
Avidity of anti malarial antibodies inversely related to transmission intensity at three sites in Uganda
8
Functional Antibody Activity Elicited by Fractional Doses ofHaemophilus influenzae Type b Conjugate Vaccine (Polyribosylribitol Phosphate–Tetanus Toxoid Conjugate)
5
Immunologic Response to Haemophilus influenzae Type b (Hib) Conjugate Vaccine and Risk Factors for Carriage among Hib Carriers and Noncarriers in Southwestern Alaska
7
Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity
9
High Throughput Multiplex Serological Testing in Microbiology
13
Isolation and characterization of human polyreactive pneumococcal polysaccharide antibodies
13
Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process.
13
Development and validation of an Enzyme Linked Immunosorbent Assay (ELISA) test for the diagnosis of toxoplasmosis in Sri Lanka
5